The global digital health monitoring devices market size was valued at USD 5.19 billion in 2024 and is expected to reach USD 20.70 billion by 2032, at a CAGR of 18.87% during the forecast period
Read MoreAccording to Intel Market Research, the global ibuprofen market is projected to grow from USD 87.4 million in 2024 to USD 106 million by 2032, registering a CAGR of 2.9%. Market expansion is driven by rising global pain management needs, healthcare infrastructure expansion in emerging economies, and increasing OTC accessibility, despite intense competition and market saturation in developed regions.
Read MoreAccording to Intel Market Research, the global diabetes drugs market is projected to grow from USD 99,880 million in 2024 to USD 218,800 million by 2032, registering a CAGR of 12.1%. Market expansion is driven by rising global diabetes prevalence, advancements in GLP-1 receptor agonists and SGLT2 inhibitors, and increasing healthcare expenditure worldwide.
Read MoreAccording to Intel Market Research, the global Over The Counter (OTC) Drugs Market is projected to grow from USD 155.1 billion in 2024 to USD 216.8 billion by 2034, registering a CAGR of 5.0%. Market expansion is driven by increasing consumer preference for self-medication, rising healthcare costs, Rx-to-OTC switches, and expanding e-commerce channels for OTC drug sales worldwide.
Read MoreThe global disease-specific medical nutrition market size was valued at USD 26.17 billion in 2025 and is expected to reach USD 48.97 billion by 2033, at a CAGR of 8.15% during the forecast period
Read More